Therapy, General practice

The prognostic value of body weight loss and anthropometry indices in patients with chronic heart failure and decreased left ventricular ejection fraction
Interaction of therapy on bone mineral density in male and female patients with rheumatoid arthritis
Prognosing the severity of the myasthenia gravis
Bioequivalence of a generic medicinal product Tiara Duo (valsartan and hydrochlorothiazide fixed-dose combination) to the reference medicinal product Co-Diovan®: results of a randomized crossover clinical trial in healthy volunteers
Bioequivalence of the medicinal product Preventor (rosuvastatin), film-coated tablets, to the reference medicinal product Crestor® (rosuvastatin), film-coated tablets, in a randomized crossover clinical trial in healthy volunteers
Bioequivalence of amlodipine, hydrochlorothiazide and valsartan fixed-dose combination generic medicinal product (Tiara Trio®) to the reference medicinal product Exforge HCT®: results of a randomized crossover clinical trial in healthy volunteers